KeyBank National Association
ATRS

KeyBank National Association’s Antares Pharma, Inc. ATRS Stock Holding History

KeyBank National Association’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,900
Closed -$206K – 1021
2019
Q4 		$206K Buy
+43,900
New +$180K ﹤0.01% 962

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

KeyBank National Association's ATRS Position: Q1 2020 in Review

KeyBank National Association sold out of Antares Pharma, Inc. (ATRS) in Q1 2020, closing a stake of 43,900 shares — an estimated $206K sold.

KeyBank National Association first reported a position in ATRS in Q4 2019 and held it in 1 quarter. The position peaked at $206K in Q4 2019. 154 funds tracked by Wall St. Rank hold ATRS as of Q1 2020.

  • KeyBank National Association reported no remaining Antares Pharma, Inc. position as of Q1 2020 after selling out during the quarter.
  • KeyBank National Association sold 43,900 Antares Pharma, Inc. shares in Q1 2020, an estimated $206K.
  • KeyBank National Association first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 1 quarter.
  • KeyBank National Association's Antares Pharma, Inc. position peaked at $206K in Q4 2019.
  • 154 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2020.

Based on KeyBank National Association's 13F filing for Q1 2020, filed 13 May 2020.